CN101181430A - Chinese medicine medicament for curing rosalia lupus - Google Patents
Chinese medicine medicament for curing rosalia lupus Download PDFInfo
- Publication number
- CN101181430A CN101181430A CNA2007103012551A CN200710301255A CN101181430A CN 101181430 A CN101181430 A CN 101181430A CN A2007103012551 A CNA2007103012551 A CN A2007103012551A CN 200710301255 A CN200710301255 A CN 200710301255A CN 101181430 A CN101181430 A CN 101181430A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- medicine
- decoction
- lupus erythematosus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 206010025135 lupus erythematosus Diseases 0.000 title claims abstract description 13
- 241000548911 Rosalia Species 0.000 title 1
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 239000010231 banlangen Substances 0.000 claims abstract description 5
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000000645 desinfectant Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 235000019658 bitter taste Nutrition 0.000 abstract description 2
- 235000009508 confectionery Nutrition 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- NEZONWMXZKDMKF-UHFFFAOYSA-N C.I. Natural Red 20 Chemical compound C1=CC(O)=C2C(=O)C(C(O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-UHFFFAOYSA-N 0.000 abstract 1
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000334154 Isatis tinctoria Species 0.000 abstract 1
- 240000004035 Lithospermum officinale Species 0.000 abstract 1
- 235000011030 Lithospermum officinale Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 241000169121 Toxicum Species 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000014347 soups Nutrition 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 206010012218 Delirium Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000000216 zygoma Anatomy 0.000 description 3
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical group Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229940040145 liniment Drugs 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine drug which cures lupus erythematosus. The invention is characterized in that: the invention is a soup granule produced by materials in the following weight rate: 30g of caulis lonicerae, 15g of forsythia, 30g of dandelion, 30g of dyers woad leaf, 20g of radix isatidis, 10g of gromwell, 15g of Herba Houttuyniae, 10g of violet, 10g of angelica, 10g of red peony root and 15g of fresh rehmannia root. The invention chooses purely natural raw materials related to the traditional Chinese medicine, wherein, each component accords with the provisions of medicinal laws, making use of the comprehensive effect of the traditional Chinese medicine. Having effects on the lupus erythematosus, the invention has no chemical sweetening agent and has no toxicum as well as harm to human body. The medicine in the invention is a little sweet in taste without bitterness and easy for being taken. Being proven in cases in clinical observation, five days is one curative period, and two times per day while 50ml per time. A patient is healed generally after three curative periods. So far, the invention is effective for nearly 1000 cases of patients, and the total effectiveness rate is 100 percent.
Description
Technical field the invention belongs to the Chinese medicine technical field of pharmaceuticals, is specifically related to a kind of Chinese medicine medicine for the treatment of lupus erythematosus.
The background technology lupus erythematosus is a common clinical, and lupus erythematosus has the deficiency of both the liver and kidney person of bringing out from etiology and pathogenesis, lid is because of liver storing blood, and kidney controlling essence storage, the asthenia of essence and blood then deficiency of YIN are given birth to interior-heat, hyperactivity of deficient fire, not close in the double natural fibre line of meat, sunlight exposure, two heat are rich mutually, in pyretic toxicity is gone into, stasis of blood resistance venation, in injure internal organs, extrernal resistance is due to the skin.Or, burn the nutrient blood of burning and cause acute attack because of excessive noxious heat.At present, clinical common employing liniment or heavy dose of oral western medicine treatment.The liniment therapeutic effect is poor, and the course of treatment is long, the cost height; Heavy dose of oral western medicine side effect is big, and the manufacturing process complexity, the production cost height.
Summary of the invention the purpose of this invention is to provide a kind for the treatment of both the principal and secondary aspects of a disease, has no side effect, the Chinese medicine medicine of short treating period, cheap treatment lupus erythematosus, to overcome the deficiencies in the prior art.
Solution of the present invention is based on understanding and the Therapeutic Principle of motherland's medical science to the pathogeny and the human body immunity improving power of lupus erythematosus, with reference to ancient, modern pharmacological research achievement, from motherland's medical treasure-house, filter out the natural Chinese medicine of heat-clearing and toxic substances removing, removing heat from blood pathogenic fire purging dissipating rashes, by the theory of Chinese medical science prescription, skim the cream off milk, make its performance promote that yang blood and qi is regulated in the human body, vital organs of the human body twelve channels and collaterals balance has the effect of rapid healing to lupus erythematosus.
Medicine of the present invention is made (consumption is a weight portion) by following component:
Caulis Lonicerae 30, Fructus Forsythiae 15, Herba Taraxaci 30, Folium Isatidis 30, Radix Isatidis 20, Radix Arnebiae (Radix Lithospermi) 10 grams, Herba Houttuyniae 15, Herba Violae 10, Radix Angelicae Sinensis 10, Radix Paeoniae Rubra 10, the Radix Rehmanniae 15;
Above-mentioned each component is made Chinese medicine decoction according to a conventional method, finishes by following step successively:
1) decoct: above-mentioned all medicines are put into marmite, add hydrology fire by 1: 2 of medicine total amount and decoct, boiled back 20 minutes, medicinal liquid is leached, 1: 1 by the medicine total amount adds the fiery decoction of the hydrology again, boils back 20 minutes, and medicinal liquid is leached;
2) bottling: seal in the disinfectant bottle in advance with packing into behind twice filtrate mixing;
3) sterilization: the medicinal liquid bottle is put into pressure cooker sterilization 20 minutes, promptly get Chinese medicine decoction of the present invention.
The clear network detoxifcation of Caulis Lonicerae in the medicine of the present invention; The Fructus Forsythiae pathogenic fire purging is loose all poly-through blood clotting gas; Herba Taraxaci, Herba Violae heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, change taste pyretic toxicity remove malignant boil and treat poison; Folium Isatidis, Radix Isatidis removing pathogen in the heart gastric heat poison, and control YANG toxin syndrome and send out speckle; The Radix Arnebiae (Radix Lithospermi) removing pathogenic heat from blood and toxic substance from the body; The Herba Houttuyniae heat-clearing and toxic substances removing, the pain that disappears is swollen; Radix Angelicae Sinensis breaks stagnant blood, supports fresh blood, controls carbuncle; The Radix Paeoniae Rubra removing heat from blood and promoting blood circulation, medicinal powder for relieving pain is swollen; The silt that disappears of Radix Rehmanniae YIN nourishing, clearing away heat-fire, removing heat from blood.Above-mentioned all medicines have specially good effect through reasonable compatibility to lupus erythematosus.
The clinical use result of medicine decoction of the present invention shows that following advantage is arranged:
1, the present invention selects the natural Chinese medicines raw material for use, and each component meets pharmaceutical control law regulation, utilizes the comprehensive function of the Chinese medicine of respectively distinguishing the flavor of, and lupus erythematosus is had the effect of healing, does not have chemical sweeting agent, and is nontoxic to human body.
2, the present invention distinguish the flavor of little sweet, no bitterness sense, taking convenience.
For showing the curative effect of medicine decoction of the present invention, case is selected in clinical observation of the present invention, and five days is a course of treatment, day clothes 2 times, and each 50ml, three courses of treatment of general therapeutic, the patient can fully recover; At present, nearly 1000 examples that heal the sick return to one's perfect health to effectively, and total effective rate is 100%.
Model case:
The Meng XX, woman, 14 years old, student.Medical history: heating, whole body pain, left side cervical lymph node enlargement are arranged before the patient, examine and be " lymphoid tuberculosis ", with Drug therapys such as " isoniazids ", lump dwindles, and erythra plays, the color purple in facial then two cheekbone places, the high skin that rises, hyperpyrexia, in a certain state of delirium, thirsty agitation, the time delirium is arranged, indigestion and loss of appetite; the urine yellow skin, be hard and dry, through the consultation of doctors of internal medicine, department of dermatologry; be diagnosed as " acute systemic lupus erythematosus ", the request treatment by Chinese herbs.
Check: facial two cheekbone purple speckle skin ulcers, absentminded, body of the tongue is deep red, and tongue is few, the pulse condition stringy and rapid pulse.
Dialectical: excessive noxious heat, go into blood system.
The rule of treatment: heat-clearing and toxic substances removing, cooling blood and dissolving purpura are main.Thoroughly recovery from illness after March, not recurrence more so far.
Further consultation: the patient took medicine five days, and heating is moved back, and spirit takes a turn for the better, and delirium ends, and appetite is promoted to some extent, and the color of two flushed cheeks speckle skin ulcers is more preceding thin out and the gesture of gradually moving back is arranged, thirsty ending, and two just transfer.Body of the tongue is deep red, and tongue is few, the pulse condition stringy and rapid pulse.
The patient continued to take medicine five days, and diseases such as facial two cheekbone speckle skin ulcers are gradually moved back, agitation have been healed, and spirit and appetite are shaken multiple; Two is just normal.Red tongue, tongue is few, pulse condition is heavy and few string; Continue and obeyed five days, the speckle skin ulcer is moved back to the greatest extent, replys health, follows up a case by regular visits to after 1 year, and body is strong as usual.
The specific embodiment
Take by weighing raw material (gram) by following proportioning
Caulis Lonicerae 30, Fructus Forsythiae 15, Herba Taraxaci 30, Folium Isatidis 30, Radix Isatidis 20, Radix Arnebiae (Radix Lithospermi) 10 grams, Herba Houttuyniae 15, Herba Violae 10, Radix Angelicae Sinensis 10, Radix Paeoniae Rubra 10, the Radix Rehmanniae 15;
Above-mentioned each component is made Chinese medicine decoction according to a conventional method, finishes by following step successively:
1) decoct: above-mentioned all medicines are put into marmite, add hydrology fire by 1: 2 of medicine total amount and decoct, boiled back 20 minutes, medicinal liquid is leached, 1: 1 by the medicine total amount adds the fiery decoction of the hydrology again, boils back 20 minutes, and medicinal liquid is leached;
2) bottling: seal in the disinfectant bottle in advance with packing into behind twice filtrate mixing;
3) sterilization: the medicinal liquid bottle is put into pressure cooker sterilization 20 minutes, promptly get Chinese medicine decoction of the present invention.
Claims (1)
1. a Chinese medicine medicine for the treatment of lupus erythematosus is characterized in that it is the decoction of being made by the following weight proportion raw material: Caulis Lonicerae 30, Fructus Forsythiae 15, Herba Taraxaci 30, Folium Isatidis 30, Radix Isatidis 20, Radix Arnebiae (Radix Lithospermi) 10 grams, Herba Houttuyniae 15, Herba Violae 10, Radix Angelicae Sinensis 10, Radix Paeoniae Rubra 10, the Radix Rehmanniae 15; Its preparation method is finished by following step successively: 1) decoct: above-mentioned all medicines are put into marmite, add the fiery decoction of the hydrology by 1: 2 of medicine total amount, boiled back 20 minutes, medicinal liquid is leached, by the medicine total amount 1: 1 adds the decoction of hydrology fire again, boils back 20 minutes, and medicinal liquid is leached; 2) bottling: seal in the disinfectant bottle in advance with packing into behind twice filtrate mixing; 3) sterilization: the medicinal liquid bottle is put into pressure cooker sterilization 20 minutes, promptly get Chinese medicine decoction of the present invention.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007103012551A CN101181430A (en) | 2007-12-18 | 2007-12-18 | Chinese medicine medicament for curing rosalia lupus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007103012551A CN101181430A (en) | 2007-12-18 | 2007-12-18 | Chinese medicine medicament for curing rosalia lupus |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101181430A true CN101181430A (en) | 2008-05-21 |
Family
ID=39446942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007103012551A Pending CN101181430A (en) | 2007-12-18 | 2007-12-18 | Chinese medicine medicament for curing rosalia lupus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101181430A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102362984A (en) * | 2011-06-15 | 2012-02-29 | 王莲芬 | A Chinese patent medicine for curing toxic erythema |
CN104107278A (en) * | 2014-07-09 | 2014-10-22 | 华洪萍 | Traditional Chinese medicament for treating systemic lupus erythematosus |
CN104840714A (en) * | 2015-05-29 | 2015-08-19 | 合肥丰瑞隆生物科技有限公司 | Traditional Chinese medicine for treating lupus erythematosus |
-
2007
- 2007-12-18 CN CNA2007103012551A patent/CN101181430A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102362984A (en) * | 2011-06-15 | 2012-02-29 | 王莲芬 | A Chinese patent medicine for curing toxic erythema |
CN102362984B (en) * | 2011-06-15 | 2013-02-13 | 王莲芬 | A Chinese patent medicine for curing toxic erythema |
CN104107278A (en) * | 2014-07-09 | 2014-10-22 | 华洪萍 | Traditional Chinese medicament for treating systemic lupus erythematosus |
CN104840714A (en) * | 2015-05-29 | 2015-08-19 | 合肥丰瑞隆生物科技有限公司 | Traditional Chinese medicine for treating lupus erythematosus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103349770B (en) | Traditional Chinese medicine composition for treating diarrhoea | |
CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
CN103720996A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
CN103705782A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
CN100596283C (en) | Traditional Chinese medicine for treating chronic appendicitis and preparing method thereof | |
CN101181430A (en) | Chinese medicine medicament for curing rosalia lupus | |
CN102512585B (en) | Traditional Chinese medicine used for treating yin deficiency and fire hyperactivity | |
CN104758726A (en) | Traditional Chinese medicine composition for treating urinary tract infection | |
CN103800689A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
CN100998824A (en) | Oral Chinese medicine for treating virus myocarditis | |
CN100542565C (en) | Oral Chinese medicine for treating migraine-type hyperhidrosis | |
CN101244194B (en) | Chinese medicine for treating scrofula disease | |
CN103550660B (en) | A kind of Chinese medicine composition for the treatment of diabetes | |
CN102813785B (en) | Preparation method of traditional Chinese medicine for treating headache-type acute glomerulonephritis | |
CN100998747A (en) | Oral traditional Chinese medicine for treating serious hyposomnia of breakdown of the normal physiological coordination between the heart and the kidney type | |
CN101095919A (en) | Chinese patent drug for treating diabetes gallstone | |
CN104027751A (en) | Traditional Chinese medicine preparation for treating chronic cholecystitis | |
CN106389782A (en) | Traditional Chinese medicinal composition for treating acute mastitis | |
CN105106922A (en) | Decoction medicine for treating stomach cancer postoperative fever and preparation method of decoction medicine | |
CN104758889A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN101991703B (en) | Traditional Chinese medicine for treating globus hysteriocus diseases | |
CN104771739A (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
CN103736066A (en) | Traditional Chinese medicine composition for treating impairment of gastric downbearing | |
CN104338034A (en) | Medicine for oral administration for treating ulcerative angina and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20080521 |